Fuji Finance Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fuji Finance Indonesia Tbk. trades at Rp218 (market cap 275.6B, 1.31M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 33.1K 24h volume). The key difference: Fuji Finance Indonesia Tbk. is the larger of the two by market cap, and Fuji Finance Indonesia Tbk. is more actively traded (1.31M versus 33.1K). Which is the better fit depends on your goals.
| FUJI | OBAT | |
|---|---|---|
Market Cap | 275.6B | 167.37B |
Volume | 1.31M | 33.1K |
Lot | 13.1K | 331 |
Turnover | 285.47M | 8.17M |
Average Price | 217.92 | 246.91 |
Value | 285.47M | 8.17M |
Indicative Equilibrium Price | 212 | 246 |
Indicative Equilibrium Volume | 8.4K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Fuji Finance Indonesia Tbk (Company) was established first with the name of PT Jaya FajarLeasing Pratama based on Notarial Deed of Kartini Muljadi S.H., No. 287 on September 211982, which was changed to Jaya Fuji Leasing Pratama on March 28, 1983, then on July 2018 the Company's name was changed to Fuji Finance Indonesia
Read more on FUJI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →